Paediatric Subanalysis of TSUBASA, Assessing Physical Activity, Bleeding, Quality of Life and Safety in People with Haemophilia A Receiving Emicizumab.

TH Open · 2026 · PMC12828975 · PMID 41583730

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

All domains showed a trend towards better QoL for adolescents (participants aged 12 to < 16 years) compared with younger children (aged 6 to < 12 years; Supplementary Table S3A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.